文献速递消化道肿瘤与早癌

乳酸乳球菌HkyuLL 10通过产生α-甘露糖苷酶抑制结直肠肿瘤发生并恢复肠道菌群

Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase.
PubMed 文献 · Gut · 2024-08-08

该研究在结直肠癌患者(n=489)和健康人(n=536)中评估乳酸乳球菌丰度,发现患者粪便中该菌耗竭;从健康人粪便分离出HkyuLL 10菌株,在Apc Min/+小鼠和致癌物诱导结直肠癌小鼠中证实其抑制肿瘤发生,并通过分泌α-甘露糖苷酶发挥抗肿瘤作用。作者认为HkyuLL 10可能作为结直肠癌的预防措施。

要点

  • 结直肠癌患者粪便乳酸乳球菌较健康人耗竭。
  • HkyuLL 10菌株在两种小鼠模型中抑制结直肠肿瘤发生。
  • HkyuLL 10分泌的α-甘露糖苷酶在细胞、类器官和异种移植小鼠中显示抗肿瘤作用。

核心结论

  • HkyuLL 10通过恢复肠道菌群和分泌功能蛋白α-甘露糖苷酶抑制小鼠结直肠肿瘤发生。
  • 作者认为给予HkyuLL 10可能作为结直肠癌的预防措施。

研究设计与样本

  • 评估结直肠癌患者(n=489)和健康人(n=536)的乳酸乳球菌丰度。
  • 从健康人粪便分离乳酸乳球菌并经全基因组测序验证,新菌株命名为HkyuLL 10。
  • 在Apc Min/+转基因小鼠和致癌物诱导结直肠癌小鼠中评估HkyuLL 10对肿瘤发生的影响。
  • 采用宏基因组测序分析粪便菌群,纳米液相色谱-质谱鉴定候选蛋白。
  • 在人结直肠癌细胞、患者来源类器官和异种移植小鼠中研究HkyuLL 10条件培养基及功能蛋白的生物学功能。

主要发现

  • 结直肠癌患者粪便乳酸乳球菌耗竭。
  • HkyuLL 10补充抑制Apc Min/+小鼠结直肠肿瘤发生,并在致癌物诱导结直肠癌小鼠中证实该抑瘤效应。
  • 菌群分析显示HkyuLL 10处理小鼠中益生菌富集,包括约氏乳杆菌。
  • HkyuLL 10条件培养基显著抑制人结直肠癌细胞和患者来源类器官生长。
  • α-甘露糖苷酶为人结直肠癌细胞和类器官中显示抗肿瘤效应的功能蛋白,其补充显著减少异种移植小鼠肿瘤生长。

临床怎么用

  • 作者认为给予HkyuLL 10可能作为结直肠癌的预防措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Probiotic Lactococcus lactis is known to confer health benefits to humans. Here, we aimed to investigate the role of L. lactis in colorectal cancer (CRC). DESIGN: L. lactis abundance was evaluated in patients with CRC (n=489) and healthy individuals (n=536). L. lactis was isolated from healthy human stools with verification by whole genome sequencing. The effect of L. lactis on CRC tumourigenesis was assessed in transgenic Apc Min/+ mice and carcinogen-induced CRC mice. Faecal microbiota was profiled by metagenomic sequencing. Candidate proteins were characterised by nano liquid chromatography-mass spectrometry. Biological function of L. lactis conditioned medium (HkyuLL 10-CM) and functional protein was studied in human CRC cells, patient-derived organoids and xenograft mice. RESULTS: Faecal L. lactis was depleted in patients with CRC. A new L. lactis strain was isolated from human stools and nomenclated as HkyuLL 10. HkyuLL 10 supplementation suppressed CRC tumourigenesis in Apc Min/+ mice, and this tumour-suppressing effect was confirmed in mice with carcinogen-induced CRC. Microbiota profiling revealed probiotic enrichment including Lactobacillus johnsonii in HkyuLL 10-treated mice. HkyuLL 10-CM significantly abrogated the growth of human CRC cells and patient-derived organoids. Such protective effect was attributed to HkyuLL 10-secreted proteins, and we identified that α-mannosidase was the functional protein. The antitumourigenic effect of α-mannosidase was demonstrated in human CRC cells and organoids, and its supplementation significantly reduced tumour growth in xenograft mice. CONCLUSION: HkyuLL 10 suppresses CRC tumourigenesis in mice through restoring gut microbiota and secreting functional protein α-mannosidase. HkyuLL 10 administration may serve as a prophylactic measure against CRC.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Su ACY, Ding X, Lau HCH, et al. Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase. Gut. 2024. PMID: 38599786. doi:10.1136/gutjnl-2023-330835

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。